L-CREATINE Trademark

Trademark Overview

On Monday, September 19, 2022, a trademark application was filed for L-CREATINE with the United States Patent and Trademark Office. The USPTO has given the L-CREATINE trademark a serial number of 97596602. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by Avry Labs LLC. The L-CREATINE trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements consisting primarily of creatine
l-creatine

General Information

Serial Number97596602
Word MarkL-CREATINE
Filing DateMonday, September 19, 2022
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7403181
Registration DateTuesday, May 28, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 29, 2023

Trademark Statements

Goods and ServicesDietary supplements consisting primarily of creatine

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 4, 2022
Primary Code005
First Use Anywhere DateMonday, March 11, 2024
First Use In Commerce DateMonday, March 11, 2024

Trademark Owner History

Party NameAvry Labs LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCasper, WY 82609
Party NameAvry Labs LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCasper, WY 82609
Party NameAvry Labs LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCasper, WY 82609

Trademark Events

Event DateEvent Description
Thursday, September 22, 2022NEW APPLICATION ENTERED
Tuesday, October 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 29, 2023ASSIGNED TO EXAMINER
Thursday, July 6, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, July 6, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, July 6, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 6, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, July 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 18, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, July 21, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, July 24, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, July 24, 2023EXAMINERS AMENDMENT E-MAILED
Monday, July 24, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 24, 2023EXAMINER'S AMENDMENT ENTERED
Monday, July 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 9, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 29, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 29, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 18, 2024USE AMENDMENT FILED
Monday, March 18, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, April 6, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, April 6, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 25, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, April 25, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 28, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

creatine primarily consisting supplements dietary